Inactivating mutations in polyadenylation factor CSTF2 disrupt intronic polyadenylation patterns and are associated with intellectual disability.
Yaroslav KainoviD, Patricia A. Foley, Rebecca Igbokwe, Mary-Alice Abbott, Ingrid M. WentzenseniD, Andres RamosiD, Tim HubbardiD, Cristina DiasiD
Abstract
Alternative polyadenylation contributes extensively to transcript diversification and is particularly prominent during neuronal differentiation; however, its contribution to monogenic neurodevelopmental disorders remains incompletely understood. CSTF2 encodes an RNA-binding subunit of the cleavage stimulation factor complex and has previously been associated with X-linked intellectual disability through a single Asp50Ala missense variant with increased RNA-binding activity. Here, we identify seven rare CSTF2 variants in ten hemizygous male probands with intellectual disability, global developmental delay and/or autism spectrum disorder, including missense, nonsense, splice-site, and frameshift variants. Functional analysis of selected variants using RNA sequencing and 3'-end-proximal sequencing in CSTF2-depleted cells identified Phe19Leu, Gln543ter, Leu555Ser as strongly functionally impairing variants. These variants predominantly reduced usage of intronic polyadenylation sites while increasing usage of downstream sites within terminal 3'UTRs. Suppressed intronic sites were enriched for GU-rich sequence elements, were more evolutionarily conserved, and showed higher predicted polyadenylation-site strength, consistent with preferential impairment of CSTF2-dependent polyadenylation. In contrast, the previously reported Asp50Ala variant produced an opposing pattern, with preferential activation of intronic polyadenylation sites, consistent with its increased RNA-binding activity. These findings indicate that both reduced and increased CSTF2 activity disrupt the balance of polyadenylation-site usage and can result in neurodevelopmental disorder. Our data provide genetic and functional support for CSTF2 as an X-linked neurodevelopmental disorder gene, identify inactivating CSTF2 variants as a disease mechanism, and implicate dysregulation of intronic polyadenylation in human intellectual disability.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Point Mutation in the RNA Recognition Motif of CSTF2 Associated with Intellectual Disability in Humans Causes Defects in 3' End Processing
Petar N. Grozdanov, Elahe Masoumzadeh, … Clinton C. MacDonald·Nucleic Acids ResearchPeer-reviewed·Aug 19, 2020
- Partial loss of CFIm25 causes aberrant alternative polyadenylation and learning deficits
Callison E Alcott, Hari Krishna Yalamanchili, … Huda Yahya Zoghbi·eLifePeer-reviewed·Apr 22, 2020
- Imbalance between RNA-binding proteins and the WAVE regulatory complex underlies the toxic gain-of-function effects of the CYFIP2 Arg87Cys variant in neurodevelopmental disorders
U Suk Kim, Yukyung Jun, … Kihoon Han·bioRxiv·Oct 30, 2026
- INTS6 loss of function disrupts transcriptional regulation in mild intellectual disability
Nelli Jalkanen, Kalevi Trontti, … Olli P. H. Pietiläinen·bioRxiv·Jul 17, 2026
- ARID5B mutations cause a neurodevelopmental syndrome with neuroinflammation episodes
Hendrikus J. van Heesbeen, Nazim Rabouhi, … Philippe M. Campeau·bioRxiv·Jan 19, 2026
- CIZ1-LOSS CAUSES FEMALE-SPECIFIC AUTOSOMAL NEURODEVELOPMENTAL DISORDER THROUGH DEFECTIVE X-INACTIVATION MAINTENANCE
Thomas Besnard, Agnese Loda, … Bertrand Isidor·medRxiv·Dec 20, 2025